Navigation Links
Fuchs North America Introduces New "Fall Harvest" Collection of Seasonings and Mixes
Date:11/5/2013

m thyme, sage, black pepper and other ingredients. Added to pan drippings, it creates the perfect gravy in just minutes.

  • Classic Compote – A sensational way to dress up fall harvest fruits including apples, cranberries, raisins and walnuts, this compote mix is a delightful blend of allspice, cinnamon, nutmeg, sugar and other ingredients. Serve it as a delicious condiment during dinner … or create a memorable dessert item such as cobbler (or simply spoon over ice cream).
  • According to Howard Cantor, Fuchs North America’s corporate research chef, the new Fall Harvest Collection builds on classic cuisine but adds some unique twists.

    “In the American agrarian tradition, the onset of the cold-weather season is synonymous with bringing in the harvest, and of ‘family, hearth and home.’ Some of our country’s most cherished recipes and meals come out of this tradition. Our Fall Harvest Collection honors that tradition, while offering some interesting new variations,” Cantor reported.

    “Take our Mountain Meat Rub, for example. It’s bold and hearty – perfect not only for beef but also for bison, venison and other wild game. Our inspiration for creating this and the other items in the Fall Harvest Collection is to offer a new twist on traditional recipes. That way, meals served for fall holiday gatherings at home or eaten out at dining establishments need never be routine,” Cantor added.

    According to Patrick Laughlin, Director of Marketing, the process by which Fuchs North America develops new seasonings, mixes and flavors is both a science and an art. “We pay very close attention to evolving consumer taste preferences, but we also experiment with many combinations of flavors,” he noted.

    “We want to help our food manufacturing customers lead the way when it comes to new taste sensations – to be distinct, not just like everyone else,” Laughlin added.

    Laughlin reported that Fuchs North America’s appro
    '/>"/>

    Source: PRWeb
    Copyright©2012 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related medicine news :

    1. North Shore-LIJ Epilepsy Center is Among the First in US and the First in New York Metro Area to Offer Combined Minimally-Invasive Surgical Procedures
    2. Fresh Wave® IAQ to Showcase Advanced Commercial Odor Management Solutions at ISSA/INTERCLEAN North America 2013
    3. Leading Natural and Organic Cosmetics Manufacturer, Essential Wholesale & Labs Moves into 58,000 Square Foot Facility in Historic Northwest Portland
    4. North America Weight Loss/Obesity Management Market Worth $139.5 Billion by 2017 - New Report by MarketsandMarkets
    5. Amada Senior Care Moves North to Corona
    6. Northern Trust to Sponsor Center for Hispanic Leadership Thought-Leadership Forum Strengthening the Hispanic Pipeline in Healthcare and Biomedical Fields
    7. Fit Body Boot Camp Fitness Franchise Opens New Nevada Location and Welcomes Dave Olesczuk as Owner of the New Las Vegas North Boot Camp
    8. Spine Institute Northwest Welcomes New Spine Surgeon
    9. Junqian (Gordon) Xu, PhD, Awarded $150,000 Grant from Radiological Society of North American Research and Education Foundation
    10. Is Dating Simply Taking Care of Someone Else's Future Spouse? Unorthodox Matchmaker Tells Singles Not to Date For too Long in New Book
    11. North Shore Eye Care Celebrates Their 50th Anniversary with a LASIK Paradise Giveaway
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
    (Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Youngsters who enter ... new study suggests. Early puberty was linked with ... poor self-image and high anxiety levels, according to the ... such as conflict with family and peers, and having ... study found. Although the study found an association ...
    (Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Teens ... likely to abuse those drugs than other teens, ... the need to conduct substance abuse assessments on ... researchers said. "Prescribers and parents don,t realize ... a professor at the University of Michigan School ...
    (Date:11/26/2014)... 25, 2014 (HealthDay News) -- Exposure to peanut protein ... allergy in infants with the skin condition eczema, a ... children in the United States are allergic to peanuts. ... food allergies, particularly peanut allergy, the researchers noted. ... to 15 months. The researchers examined the amount of ...
    (Date:11/26/2014)... Randy Dotinga HealthDay Reporter ... drugs such as Prilosec and Nexium may disrupt the makeup ... of infections and other problems, a small new study suggests. ... it more likely users will become ill, and study authors ... inhibitors. However, these antacids "should be used at the ...
    Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
    ... patients with the blood cancer , , WEDNESDAY, July 9 ... once-banned drug thalidomide for patients with myeloma have learned ... is to science: Don,t judge results too early. , ... increased the odds of a complete remission, but not ...
    ... Weight Watchers,International, Inc. (NYSE: WTW ) will release ... close on Thursday, July 31, 2008., The Company ... at 5:00,p.m. ET. During the conference call, David Kirchhoff, ... Officer, will discuss,second quarter results and answer questions from ...
    ... its,efforts to ensure the State,s leaders are putting patients ... for Patient Care (CPC), a,non-profit, patient-advocacy organization, hand delivered ... as other key leaders in the,State Legislature today., ... with a better,understanding of how devastating these massive health ...
    ... be done without destroying embryo , , WEDNESDAY, July 9 ... in developing human embryonic stem cells earlier in the ... embryo, so the whole embryo is not destroyed. , ... European Society of Human Reproduction & Embryology annual conference ...
    ... Pain Centers (SCPC) have been shown to perform better ... for Medicare and Medicaid Services (CMS) as compared to ... an Emory University researcher. , The findings, ... for observation medicine in the Emory University School of ...
    ... Holdings, Inc.,(NYSE and SWX: ZMH) announced today its second ... live over the Internet on,Thursday, July 24, 2008, at ... results will be made available at 7:00 a.m. the,morning ... can be accessed via Zimmer,s Investor Relations,website at ...
    Cached Medicine News:Health News:Thalidomide Continues to Show Benefits Against Myeloma 2Health News:Thalidomide Continues to Show Benefits Against Myeloma 3Health News:Weight Watchers Announces Second Quarter 2008 Earnings Conference Call 2Health News:CPC Hand-Delivers Patient Testimonies to State Leaders Pleading for No Budget Cuts to Health and Human Services 2Health News:New Technique Harvests Stem Cells at Earlier Stage 2Health News:New Technique Harvests Stem Cells at Earlier Stage 3Health News:Chest pain center accreditation linked with better outcomes in heart attack patients 2
    (Date:11/26/2014)...  Medtronic,s roughly $43 billion acquisition and ... in the media for its US Federal tax ... player in one of the fastest growing device ... research firm said  the two companies compete in ... of solutions spanning inpatient to home care, and ...
    (Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
    (Date:11/26/2014)... OAKS, Calif. and LONDON , ... ) and AstraZeneca (NYSE: AZN ) today announced ... evaluating two doses of brodalumab in more than 1,800 patients ... with both Stelara ® (ustekinumab) and placebo at week ... brodalumab weight-based analysis group were each shown to be superior ...
    Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
    Intermittent catheter...
    Intermittent catheter...
    Intermittent catheter...
    ... proBNP assay is a rapid and accurate bedside ... system assisting the diagnosis and assessment of patients ... both speed and accuracy profit from ... proBNP assay = 12 minutes. In emergency departments ...
    Medicine Products: